<DOC>
	<DOC>NCT00613587</DOC>
	<brief_summary>This study is looking for allergic asthmatics. Lung and allergy testing will be done to verify. If qualified, blood will be drawn for laboratory studies.</brief_summary>
	<brief_title>Roflumilast In-Vitro Basophil Release</brief_title>
	<detailed_description>Non-smoking allergic asthmatics will be verified using pulmonary function, skin prick testing, exhaled nitric oxide and serum IgE. If qualified, blood will be drawn, treated with study medication and then stimulated with the allergen to which the subject is allergic. Mediators including Histamine, IL-13, IL-4, and leukotrienes will be measured.</detailed_description>
	<mesh_term>Histamine</mesh_term>
	<criteria>Age 19 and above Allergic Asthma Serum IgE greater than 30iu/ml Exhaled Nitric Oxide greater than 17ppb smoking history</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Interleukin 13</keyword>
	<keyword>Interleukin 4</keyword>
	<keyword>Leukotrienes</keyword>
	<keyword>Basophil Histamine Release</keyword>
</DOC>